KDAG.F Stock Overview
Provides solutions and services to pharmacies and pharmaceutical companies in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
KDA Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.28 |
| 52 Week High | CA$0.28 |
| 52 Week Low | CA$0.14 |
| Beta | 1.07 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 101.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| KDAG.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -3.3% | -0.6% |
| 1Y | n/a | 5.1% | 25.4% |
Return vs Industry: Insufficient data to determine how KDAG.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how KDAG.F performed against the US Market.
Price Volatility
| KDAG.F volatility | |
|---|---|
| KDAG.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: KDAG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine KDAG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Marc Lemieux | groupekda.ca |
KDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.
KDA Group Inc. Fundamentals Summary
| KDAG.F fundamental statistics | |
|---|---|
| Market cap | US$48.89m |
| Earnings (TTM) | US$142.26k |
| Revenue (TTM) | US$136.65k |
343.7x
P/E Ratio357.8x
P/S RatioIs KDAG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KDAG.F income statement (TTM) | |
|---|---|
| Revenue | CA$186.28k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$186.28k |
| Other Expenses | -CA$7.66k |
| Earnings | CA$193.93k |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0011 |
| Gross Margin | 100.00% |
| Net Profit Margin | 104.11% |
| Debt/Equity Ratio | 6.2% |
How did KDAG.F perform over the long term?
See historical performance and comparison